Madhavan (Madhu) Balachandran

Independent Director of Multiple Companies

Madhavan Balachandran has served as a member of our board since 2019 and was appointed interim CEO from December 2023 to March 2024 at which time James Robinson was appointed as CEO. Mr. Balachandran is a biopharma industry executive and has more than 40 years of experience in manufacturing and operations. He was previously with Amgen Inc., where he served as Executive Vice President of Operations, overseeing global operations and reporting directly to the CEO. Mr. Balachandran held similar senior operations positions at Burroughs Wellcome Co. Mr. Balachandran holds a Master’s degree in Business Administration from East Carolina University, a Master’s degree in Chemical Engineering from The State University of New York Buffalo, and a Bachelor’s degree in chemical engineering from The Indian Institute of Technology Mumbai.